Singapore markets open in 2 hours

Oncotelic Therapeutics, Inc. (OTLC)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0382-0.0005 (-1.29%)
At close: 01:46PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 15.29M
Enterprise value 27.69M
Trailing P/E 2.38
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)216.48
Price/book (mrq)1.26
Enterprise value/revenue N/A
Enterprise value/EBITDA 2.66

Trading information

Stock price history

Beta (5Y monthly) 0.03
52-week change 30.00%
S&P500 52-week change 326.27%
52-week high 30.0500
52-week low 30.0100
50-day moving average 30.0398
200-day moving average 30.0358

Share statistics

Avg vol (3-month) 362.62k
Avg vol (10-day) 316.83k
Shares outstanding 5399.68M
Implied shares outstanding 6399.68M
Float 8180.54M
% held by insiders 154.97%
% held by institutions 10.00%
Shares short (15 Nov 2016) 4662.75k
Short ratio (15 Nov 2016) 48.04
Short % of float (15 Nov 2016) 42.50%
Short % of shares outstanding (15 Nov 2016) 42.50%
Shares short (prior month 14 Oct 2016) 4812.77k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 328 Dec 2012

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-806.96%

Management effectiveness

Return on assets (ttm)-1.07%
Return on equity (ttm)-53.28%

Income statement

Revenue (ttm)70k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -552.03k
Net income avi to common (ttm)-7.9M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)170.41k
Total cash per share (mrq)0
Total debt (mrq)12.57M
Total debt/equity (mrq)108.29%
Current ratio (mrq)0.02
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-1.32M
Levered free cash flow (ttm)-580.54k